Ginkgolide B belongs to families of ginkgo diterpene lipids, which are terpenes extracted from Ginkgo biloba. Ginkgolide B is both the platelet-activating factor (PAF) receptor antagonist and a nonspecific central nervous glycine receptor antagonist which can upregulate BDNF and inhibits the release of intracellular calcium ion and NO. Due to the complexity of its structure, its solubility and bioavailability are the most important factors affecting druggability. With the further study, this compound will be used in clinical better.
KeywordsGinkgolide B Ginkgo biloba PAFR antagonist Glycine receptor antagonist
- 1.Furukawa S. Constituents of Ginkgo biloba leaves. Sci Pap Inst Phys Chem Res. 1932;19:27–38.Google Scholar
- 2.Woods MC, Miura I, Nakadaira Y, Ginkgolides V. Some aspects of their N.M.R. spectra. Tetrahedron Lett. 1967;(4):321–6.Google Scholar
- 4.Park PU, Pyo S, Lee SK. Ginkgolide derivatives. 1996.Google Scholar
- 7.Braquet P. Proofs of involvement of PAF-acether in various immune disorders using BN 52021 (ginkgolide B): a powerful PAF-acether antagonist isolated from Ginkgo biloba L. Adv Prostaglandin Thromboxane Leukot Res. 1985;16:179–98.Google Scholar
- 9.Liu X, Sun W, Zhao Y. Ginkgolide B inhibits JAMA, Cx43, and VE-cadherin expression and reduces monocyte transmigration in oxidized LDL-stimulated human umbilical vein endothelial cells. Oxidative Med Cell Longev. 2015;2015:907926.Google Scholar